These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24534655)

  • 21. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric morphea (localized scleroderma): review of 136 patients.
    Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
    J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphea and localized scleroderma in children.
    Vierra E; Cunningham BB
    Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep morphea.
    Bielsa I; Ariza A
    Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Localized scleroderma (morphea)].
    Bono W; Dupin N
    Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of morphea (localized scleroderma).
    Peterson LS; Nelson AM; Su WP
    Mayo Clin Proc; 1995 Nov; 70(11):1068-76. PubMed ID: 7475336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study.
    Vasquez R; Jabbar A; Khan F; Buethe D; Ahn C; Jacobe H
    J Am Acad Dermatol; 2014 Mar; 70(3):481-8. PubMed ID: 24365168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Children with morphea have normal self-perception.
    Uziel Y; Laxer RM; Krafchik BR; Yeung RS; Feldman BM
    J Pediatr; 2000 Nov; 137(5):727-30. PubMed ID: 11060543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory arthritis in pediatric patients with morphea.
    Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
    J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphea: a practical review of its diagnosis, classification and treatment.
    Rodríguez-Salgado P; García-Romero MT
    Gac Med Mex; 2019; 155(5):483-491. PubMed ID: 32091025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphea disease activity during pregnancy: A case series.
    Walker AM; Bermas BL; Jacobe HT
    J Dermatol; 2022 Dec; 49(12):1278-1283. PubMed ID: 36093764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphea in Childhood: An Update.
    Aranegui B; Jiménez-Reyes J
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):312-322. PubMed ID: 29248149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of LPG treatment in morphea.
    Worret WI; Jessberger B
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):527-30. PubMed ID: 15324386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.
    Mansour M; Liy Wong C; Zulian F; Li S; Morishita K; Yeh EA; Stewart K; Laxer RM; Pope E
    Pediatr Dermatol; 2018 Nov; 35(6):761-768. PubMed ID: 30187959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
    Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K
    JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in diagnosis and assessment of morphea.
    Nouri S; Jacobe H
    Curr Rheumatol Rep; 2013 Feb; 15(2):308. PubMed ID: 23307579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.
    Jacobe H; Ahn C; Arnett FC; Reveille JD
    Arthritis Rheumatol; 2014 Nov; 66(11):3170-7. PubMed ID: 25223600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.
    Ardalan K; Zigler CK; Torok KS
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1082-1087. PubMed ID: 27696700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.